Myopia primary prevention
Please help WikiDoc by more adding content here. It’s easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2] Associate Editor(s)-in-Chief: Saumya Easaw, M.B.B.S.[3]
Primary Prevention
Primary Prevention
There is no universally accepted method of preventing myopia. Some clinicians and researchers recommend plus power (convex) lenses in the form of single vision reading lenses or bifocals.[1] A recent Malaysian study reported in New Scientist[2] suggested that undercorrection of myopia caused more rapid progression of myopia,[3] However, the reliability of this data has been called into question.[4] Many myopia treatment studies suffer from any of a number of design drawbacks:
- Lack of adequate control group,
- Failure to mask examiners from knowledge of treatments used, etc.
Pirenzepine eyedrops had a limited effect on retarding myopic progression in a recent, placebo-control, double-blinded prospective controlled study[5].
References
References
- ↑ Rehm, Donald “The Myopia Myth-The Truth About Nearsightedness And How To Prevent It” Chapter 6 Published by The International Myopia Prevention Assn., 1054 Gravel Hill Road, Ligonier, PA 15658. 1981 ISBN 0-9608476-0-X
- ↑ Andy Coghlan and Michael Le Page (20 November 2002). “Eye correction is seriously short sighted”. New Scientist.
- ↑ Chung K, Mohidin N, O’Leary DJ. “Undercorrection of myopia enhances rather than inhibits myopia progression.” Vision Res. 2002 Oct;42(22):2555-9. PMID 12445849.
- ↑ The Wildoset Lab. “Controlling Myopia Progression – A Confusing Story”. Retrieved September 1, 2006.
- ↑ Siatkowski R, Cotter S, Miller J, Scher C, Crockett R, Novack G (2004). “Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study”. Arch Ophthalmol. 122 (11): 1667–74. PMID 15534128.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH